SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Erin E. Gabriel, Michael C. Sachs, Peter B. Gilbert, Comparing and combining biomarkers as principle surrogates for time-to-event clinical endpoints, Statistics in Medicine, 2015, 34, 3
  2. 2
    Peter B. Gilbert, Erin E. Gabriel, Ying Huang, Ivan S.F. Chan, Surrogate Endpoint Evaluation: Principal Stratification Criteria and the Prentice Definition, Journal of Causal Inference, 2015, 3, 2

    CrossRef

  3. 3
    Luca Moraschini, Irene Passalacqua, Monica Fabbrini, Immaculada Margarit Y Ros, Fabio Rigat, Threshold-free estimation of functional antibody titers of a group B streptococcus opsonophagocytic killing assay, Pharmaceutical Statistics, 2015, 14, 3
  4. 4
    E. E. Gabriel, P. B. Gilbert, Evaluating principal surrogate endpoints with time-to-event data accounting for time-varying treatment efficacy, Biostatistics, 2014, 15, 2, 251

    CrossRef

  5. 5
    Peter B. Gilbert, Erin E. Gabriel, Xiaopeng Miao, Xiaoming Li, Shu-Chih Su, Janie Parrino, Ivan S. F. Chan, Fold Rise in Antibody Titers by Measured by Glycoprotein-Based Enzyme-Linked Immunosorbent Assay Is an Excellent Correlate of Protection for a Herpes Zoster Vaccine, Demonstrated via the Vaccine Efficacy Curve, Journal of Infectious Diseases, 2014, 210, 10, 1573

    CrossRef

  6. 6
    Julian Wolfson, Lisa Henn, Hard, harder, hardest: principal stratification, statistical identifiability, and the inherent difficulty of finding surrogate endpoints, Emerging Themes in Epidemiology, 2014, 11, 1, 14

    CrossRef